ACG's latest modular hollow capsule production machine is helping drive capacity expansion for nutraceutical producers in India, the company announced following successful installations across multiple contract manufacturers. The modular design allows producers to add production modules incrementally, aligning capital investment with market uptake.
ACG's solution targets mid-size producers who need to scale quickly without committing to a single, large-capex line. The machine's architecture separates shell production, fill metering, and finishing modules, enabling phased commissioning. Clients can start with a basic hollow capsule shell mold and later add high-speed fill and inspection modules as demand grows.
This modularity reduces time-to-market and lowers initial investment barriers for domestic brands expanding into softgel categories.In one illustrative case, a Pune-based contract manufacturer partnered with ACG to replace manual post-processing steps with integrated automation. The new line cut manual labor by nearly 40% and improved throughput while retaining product quality for omega-3 and herbal oil softgels.
The manufacturer also benefited from improved occupational safety through enclosed processing and automated material handling.ACG's engineering team emphasized the machine's adaptability to local manufacturing environments: robust controls, simplified maintenance, and remote diagnostic capabilities reduce downtime in regions where specialized service availability can be limited.
The system supports multiple shell and fill recipes and can be configured for co-extrusion shells and multi-segment fills, which are gaining traction in value-added nutraceutical products.Quality control features include real-time weight checks, high-speed visual inspection for shell integrity, and automated sorting for out-of-spec capsules. Integration with manufacturing execution systems (MES) allows customers to track production KPIs and maintain traceable batch records required by auditors and regulators.Beyond the technology, ACG's local service model - including on-site commissioning and operator training - has been a decisive factor for many customers.
The company's aftermarket support reduces the learning curve for operators transitioning from older equipment to modular, digitally managed production lines.Analysts observe that modular encapsulation lines are well-suited to India's rapidly evolving nutraceutical sector, where brands seek to differentiate through complex formulations and faster product rollouts.
By enabling phased investment, the modular approach reduces financial risk while preserving scalability.For local contract manufacturers, adopting such modular systems supports export ambitions by meeting international quality expectations.
ACG's deployments in India illustrate how accessible automation can accelerate industry maturation and help domestic brands expand into regulated export markets.
